SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 185 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $466 | -8.1% | 16,886 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $507 | -12.3% | 16,886 | +5.9% | 0.01% | -16.7% |
| Q1 2023 | $578 | +1.8% | 15,947 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $568 | -99.9% | 15,947 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $540,000 | +11.6% | 15,947 | +6.4% | 0.01% | +20.0% |
| Q1 2022 | $484,000 | +10.8% | 14,981 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $437,000 | +9.2% | 14,981 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $400,000 | -13.2% | 14,981 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $461,000 | +17.6% | 14,981 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $392,000 | -6.7% | 14,981 | -10.2% | 0.00% | 0.0% |
| Q4 2020 | $420,000 | +20.7% | 16,681 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $348,000 | -12.1% | 16,681 | 0.0% | 0.00% | -20.0% |
| Q2 2020 | $396,000 | +32.0% | 16,681 | 0.0% | 0.01% | +25.0% |
| Q1 2020 | $300,000 | -27.2% | 16,681 | -4.0% | 0.00% | -20.0% |
| Q4 2019 | $412,000 | -13.8% | 17,381 | 0.0% | 0.01% | -16.7% |
| Q3 2019 | $478,000 | -16.9% | 17,381 | 0.0% | 0.01% | -14.3% |
| Q2 2019 | $575,000 | -5.6% | 17,381 | 0.0% | 0.01% | -12.5% |
| Q1 2019 | $609,000 | +5.5% | 17,381 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $577,000 | -34.1% | 17,381 | 0.0% | 0.01% | -20.0% |
| Q3 2018 | $875,000 | -19.1% | 17,381 | -3.9% | 0.01% | -23.1% |
| Q2 2018 | $1,082,000 | +30.7% | 18,081 | 0.0% | 0.01% | +30.0% |
| Q1 2018 | $828,000 | +22.3% | 18,081 | +6.4% | 0.01% | +25.0% |
| Q4 2017 | $677,000 | -0.4% | 17,000 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $680,000 | -14.7% | 17,000 | -8.1% | 0.01% | -20.0% |
| Q2 2017 | $797,000 | +37.7% | 18,500 | 0.0% | 0.01% | +42.9% |
| Q1 2017 | $579,000 | +48.8% | 18,500 | +20.1% | 0.01% | +40.0% |
| Q4 2016 | $389,000 | -4.2% | 15,400 | -6.1% | 0.01% | 0.0% |
| Q3 2016 | $406,000 | +21.6% | 16,400 | 0.0% | 0.01% | +25.0% |
| Q2 2016 | $334,000 | +33.6% | 16,400 | 0.0% | 0.00% | +33.3% |
| Q1 2016 | $250,000 | +13.6% | 16,400 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $220,000 | +201.4% | 16,400 | +215.4% | 0.00% | +200.0% |
| Q3 2015 | $73,000 | -17.0% | 5,200 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $88,000 | – | 5,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |